跳至主要内容
临床试验/NCT00000330
NCT00000330撤回2 期

Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-2

University of Colorado, Denver2 个研究点 分布在 1 个国家开始时间: 1999年10月最近更新:
适应症
相关药物

试验速览

阶段
2 期
状态
撤回
试验地点
2
主要终点
Observed withdrawal rating

研究概览

简要总结

The purpose of this study is to assess the abuse liability and reinforcing effects of intravenous buprenorphine and buprenorphine/naloxone combinations in heroin-dependent volunteers

详细描述

not available at this time

研究设计

研究类型
Interventional
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Individuals must be at least 18 yrs of age, currently opioid dependent and must not be seeking treatment. Co-morbid substance abuse or dependence disorders may also be present. Individuals must be healthy despite drug dependency and have a history of IV opioid use.

排除标准

  • Individuals with evidence of an active Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) Axis I psychiatric disorder (e.g. psychosis, manic-depressive illness, organic psychiatric disorders), significant medical illness (e.g. liver or cardiovascular disease) or pregnant female subjects are excluded from study participation.

结局指标

主要结局

Observed withdrawal rating

Pupil diameter

Opioid antagonist rating

Drug effect characteristics

Drug/Money Preferences

Subjective dose estimate

Analog rating scale for drug effects

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验